{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:14:41Z","timestamp":1785406481118,"version":"3.56.0"},"reference-count":52,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["1ZICHL005090-20"],"award-info":[{"award-number":["1ZICHL005090-20"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"award":["1ZICHL005090-20"],"award-info":[{"award-number":["1ZICHL005090-20"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Synaptic vesicle glycoprotein 2A (SV2A) is a 12-pass transmembrane protein expressed in presynaptic vesicles. Positron emission tomography (PET) imaging of SV2A provides an in vivo measure of synaptic density and has broad applications in the study of neuropsychiatric and neurodegenerative diseases. A fluorine-18-labeled PET tracer targeting SV2A, [18F]SynVesT-1, was originally developed using a copper-mediated fluorination approach that requires initial azeotropic drying of [18F]fluoride with anhydrous acetonitrile. We previously established an efficient radiolabeling strategy in which fluorine-18 retained on an anion-exchange cartridge is eluted as 4-dimethylaminopyridinium [18F]fluoride (DMAPH\u00b7[18F]F) by passing a solution of 4-dimethylaminopyridinium trifluoromethanesulfonate (DMAPH\u00b7OTf) in dimethylacetamide (DMA), which was directly used in copper-mediated fluorination of various substrates without the need for azeotropic drying. Building on this strategy, we developed a fully automated and reproducible method for the synthesis of [18F]SynVesT-1 using the Trasis All-in-One (AIO) module. The total synthesis time was 60 min, affording a superior overall decay-corrected radiochemical yield (30\u201337% vs. 20.6 \u00b1 1.2%) while requiring a reduced amount of precursor (2 mg vs. 5 mg) with a radiochemical purity greater than 98%.<\/jats:p>","DOI":"10.3390\/molecules31132396","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:19:31Z","timestamp":1783430371000},"page":"2396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fully Automated Azeotropic Drying-Free Synthesis of [18F]SynVesT-1 via Copper-Mediated Fluorination Using the Trasis All-in-One Module"],"prefix":"10.3390","volume":"31","author":[{"given":"Falguni","family":"Basuli","sequence":"first","affiliation":[{"name":"Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4866-9449","authenticated-orcid":false,"given":"Jianfeng","family":"Shi","sequence":"additional","affiliation":[{"name":"Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-7202","authenticated-orcid":false,"given":"Rolf E.","family":"Swenson","sequence":"additional","affiliation":[{"name":"Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1073\/pnas.90.6.2150","article-title":"Brain contains two forms of synaptic vesicle protein 2","volume":"90","author":"Bajjalieh","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcdb.2019.02.003","article-title":"Synaptic vesicle protein 2: A multi-faceted regulator of secretion","volume":"95","author":"Ciruelas","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rossi, R., Arjmand, S., B\u00e6rentzen, S.L., Gjedde, A., and Landau, A.M. (2022). Synaptic Vesicle Glycoprotein 2A: Features and Functions. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.864514"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27420","DOI":"10.1038\/srep27420","article-title":"Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission","volume":"6","author":"Tokudome","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12264-023-01138-2","article-title":"Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil","volume":"40","author":"Wu","year":"2024","journal-title":"Neurosci. Bull."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.119.261149","article-title":"Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor","volume":"372","author":"Wood","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2012.05.050","article-title":"Synaptic changes in Alzheimer\u2019s disease and its models","volume":"251","author":"Pozueta","year":"2013","journal-title":"Neuroscience"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-025-61497-4","article-title":"Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer\u2019s disease","volume":"16","author":"Luan","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Meftah, S., and Gan, J. (2023). Alzheimer\u2019s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression. Front. Synaptic Neurosci., 15.","DOI":"10.3389\/fnsyn.2023.1129036"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bod, R., T\u00f3th, K., Essam, N., T\u00f3th, E.Z., Er\u00f5ss, L., Entz, L., Bag\u00f3, A.G., Fab\u00f3, D., Ulbert, I., and Wittner, L. (2023). Synaptic alterations and neuronal firing in human epileptic neocortical excitatory networks. Front. Synaptic Neurosci., 15.","DOI":"10.3389\/fnsyn.2023.1233569"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cano, A., Fonseca, E., Ettcheto, M., S\u00e1nchez-L\u00f3pez, E., de Rojas, I., Alonso-Lana, S., Morat\u00f3, X., Souto, E.B., Toledo, M., and Boada, M. (2021). Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101057"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"180138","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: An overview of induced pluripotent stem-cell-based disease models","volume":"8","author":"Taoufik","year":"2018","journal-title":"Open Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chen, Y.-J., Xie, M.-R., Zhou, S.-Q., and Liu, F. (2025). Synapses-associated research in Parkinson\u2019s disease: An explored trends analysis. Front. Aging Neurosci., 17.","DOI":"10.3389\/fnagi.2025.1537119"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102673","DOI":"10.1016\/j.omtn.2025.102673","article-title":"MicroRNAs and synaptic dysfunction in Parkinson\u2019s disease","volume":"36","author":"Ogwo","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yeo, X.Y., Lim, Y.T., Chae, W.R., Park, C., Park, H., and Jung, S. (2022). Alterations of presynaptic proteins in autism spectrum disorder. Front. Mol. Neurosci., 15.","DOI":"10.3389\/fnmol.2022.1062878"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: Synaptic dysfunction in neurological disorders\u2014A review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13578-025-01369-y","article-title":"Altered synaptic homeostasis: A key factor in the pathophysiology of depression","volume":"15","author":"Wang","year":"2025","journal-title":"Cell Biosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e22276","DOI":"10.1002\/syn.22276","article-title":"Synaptic dysfunction in schizophrenia","volume":"77","author":"Akay","year":"2023","journal-title":"Synapse"},{"key":"ref_19","first-page":"478","article-title":"Synaptic plasticity in schizophrenia pathophysiology","volume":"13","author":"Zhang","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0002-9440(10)64645-7","article-title":"Synaptic vesicle protein 2, A new neuroendocrine cell marker","volume":"157","author":"Lukinius","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12022-019-09584-3","article-title":"Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma","volume":"30","author":"Georgantzi","year":"2019","journal-title":"Endocr. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117548","DOI":"10.1016\/j.biopha.2024.117548","article-title":"Synaptic vesicle protein 2-targeted doxorubicin-loaded liposome for effective neuroblastoma therapy","volume":"180","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bavarsad, M.S., and Grinberg, L.T. (2024). SV2A PET imaging in human neurodegenerative diseases. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1380561"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41386-024-01943-x","article-title":"Synaptic changes in psychiatric and neurological disorders: State-of-the art of in vivo imaging","volume":"50","author":"Howes","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"796129","DOI":"10.3389\/fnins.2022.796129","article-title":"Imaging Synaptic Density: The Next Holy Grail of Neuroscience?","volume":"16","author":"Serrano","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1177\/0271678X17724947","article-title":"Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans","volume":"38","author":"Finnema","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jfluchem.2006.09.015","article-title":"Fluorine-18 and medical imaging: Radiopharmaceuticals for positron emission tomography","volume":"127","year":"2006","journal-title":"J. Fluor. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1134\/S1063779608040060","article-title":"Commercial cyclotrons. Part I: Commercial cyclotrons in the energy range 10\u201330 MeV for isotope production","volume":"39","author":"Papash","year":"2008","journal-title":"Phys. Part. Nucl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1088\/0031-9155\/44\/3\/019","article-title":"Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution","volume":"44","author":"Levin","year":"1999","journal-title":"Phys. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acs.chemrev.5b00493","article-title":"18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography","volume":"116","author":"Preshlock","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1002\/anie.201407065","article-title":"C(sp3)\u201418F Bond Formation by Transition-Metal-Based [18F]Fluorination","volume":"53","author":"Liang","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/anie.201410288","article-title":"Late-Stage Fluorination: Fancy Novelty or Useful Tool?","volume":"54","author":"Neumann","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1021\/acs.joc.1c01474","article-title":"18F-Fluorination: Challenge and Opportunity for Organic Chemists","volume":"86","author":"Halder","year":"2021","journal-title":"J. Org. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00259-003-1330-y","article-title":"Positron flight in human tissues and its influence on PET image spatial resolution","volume":"31","author":"Andreo","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acschemneuro.8b00526","article-title":"Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates","volume":"10","author":"Li","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, Y., Lin, Q., Shi, H., and Cheng, D. (2022). Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.884517"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e202300072","DOI":"10.1002\/tcr.202300072","article-title":"Spirocyclic Iodonium Ylides for Fluorine-18 Radiolabeling of Non-Activated Arenes: From Concept to Clinical Research","volume":"23","author":"Pees","year":"2023","journal-title":"Chem. Rec."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1038\/srep09941","article-title":"Sulfonium Salts as Leaving Groups for Aromatic Labelling of Drug-like Small Molecules with Fluorine-18","volume":"5","author":"Sander","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/acs.orglett.6b02911","article-title":"Copper-Mediated Radiofluorination of Arylstannanes with [18F]KF","volume":"18","author":"Makaravage","year":"2016","journal-title":"Org. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1021\/acs.orglett.5c02055","article-title":"Ethyl Pinacol Boronates as Advantageous Precursors for Copper-Mediated Radiofluorination","volume":"27","author":"Hadjipaschalis","year":"2025","journal-title":"Org. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44303-025-00087-x","article-title":"Copper-mediated radiochemistry: Historical impact, current trends, and future possibilities","volume":"3","author":"Bowden","year":"2025","journal-title":"npj Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1039\/C6CC03295H","article-title":"Enhanced copper-mediated 18F-fluorination of aryl boronic esters provides eight radiotracers for PET applications","volume":"52","author":"Preshlock","year":"2016","journal-title":"Chem. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jlcr.4002","article-title":"Good manufacturing procedure production of [18F]SynVesT-1, a radioligand for in vivo positron emission tomography imaging of synaptic vesicle glycoprotein 2A","volume":"65","author":"Dahl","year":"2022","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s41181-024-00284-w","article-title":"GMP-compliant automated radiosynthesis of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A)","volume":"9","author":"Chen","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jlcr.3705","article-title":"An azeotropic drying-free approach for copper-mediated radiofluorination without addition of base","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/acs.orglett.5b02875","article-title":"Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids","volume":"17","author":"Mossine","year":"2015","journal-title":"Org. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1002\/chem.201405586","article-title":"Copper-mediated aromatic radiofluorination revisited: Efficient production of PET tracers on a preparative scale","volume":"21","author":"Zlatopolskiy","year":"2015","journal-title":"Chemistry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41181-019-0079-y","article-title":"Fast and efficient copper-mediated 18F-fluorination of arylstannanes, aryl boronic acids, and aryl boronic esters without azeotropic drying","volume":"4","author":"Lahdenpohja","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/13\/2396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:33:54Z","timestamp":1783571634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/13\/2396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":52,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["molecules31132396"],"URL":"https:\/\/doi.org\/10.3390\/molecules31132396","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}